EUVIMEDEUVIMED entdecken
Crossref

Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification

Yifan Li

International Journal of Pharma Medicine and Biological Sciences · 01.01.2026 · 34

DOI: 10.18178/ijpmbs.15.2.34-37 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharma Medicine and Biological Sciences, online erschienen am 01.01.2026. Verfasst von Yifan Li.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric Antigen Receptor (CAR)-T cell therapy has achieved remarkable success in the treatment of hematological malignancies, but its efficacy in solid tumors is still severely limited by T cell exhaustion.As one of the core regulators of T cell exhaustion, Programmed Cell Death Protein 1 (PD-1) plays a key role in this process.However, current targeting strategies for PD-1 still have inherent limitations, making it difficult to strike a balance between effective anti-tumor and maintenance of immune homeostasis.This article proposes a new regulatory strategy that uses PRIME editing technology to precisely modify the PD-1 promoter.As a new generation of gene editing tools, PRIME can achieve precise replacement at the single nucleotide level without inducing DNA double-strand breaks.By precisely modifying key regulatory elements in the PD-1 promoter region, this strategy can moderately downregulate PD-1 expression and effectively alleviate T cell exhaustion while retaining partial PD-1 function to maintain immune homeostasis.This regulatory idea provides a new technical path and theoretical support for the future construction of universal CAR-T cells with low exhaustion and high persistence.

Zitieren

APA

Li, Y. (2026). Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification. International Journal of Pharma Medicine and Biological Sciences, 34. https://doi.org/10.18178/ijpmbs.15.2.34-37

Vancouver

Li Y. Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification. International Journal of Pharma Medicine and Biological Sciences. 2026:34. doi:10.18178/ijpmbs.15.2.34-37

BibTeX
@article{Li2026,
  author = {Li, Yifan},
  title = {Engineering CAR-T Cells Based on PRIME Editing Technology: A New Strategy to Overcome T Cell Exhaustion through PD-1 Promoter Modification},
  journal = {International Journal of Pharma Medicine and Biological Sciences},
  year = {2026},
  pages = {34},
  doi = {10.18178/ijpmbs.15.2.34-37}
}
Kostenlos starten →